World Patient Safety Congress Americas 2026 Boston
Trade Shows
Generative AI, Automation & PV Technology
Real-World Evidence (RWE) & Pharmacoepidemiology
Global Regulatory Compliance & Risk Minimization
Patient-Centric Therapeutics & Consumer Product Safety
THE AMERICAS’ PREMIER B2B CONGRESS FOR PHARMACOVIGILANCE, DRUG SAFETY & PATIENT RISK MANAGEMENT ARRIVES IN BOSTON!
Organized by Terrapinn Holdings Ltd, the 2026 edition of the World Patient Safety Congress Americas (formerly the World Drug Safety Congress Americas) brings together over 1,800+ C-suite biopharma executives, global pharmacovigilance (PV) directors, clinical epidemiologists, regulatory authorities, and safety data innovators from across the globe!
Hosted across the state-of-the-art Thomas M. Menino Convention & Exhibition Center (BCEC) in Boston, Massachusetts, United States, this high-stakes 3-day international congress serves as the biopharmaceutical sector’s central safety intelligence and technology floor—connecting AI-driven signal detection platforms, real-world evidence (RWE) software, automated risk management systems, and post-market surveillance solutions directly with drug safety officers and clinical development leaders!
📅 Dates: Tuesday, October 13 – Thursday, October 15, 2026 (Pre-Congress Workshops: Oct 13 | Main Congress & Expo: Oct 14–15)
⏰ Hours: Daily Keynotes, Track Sessions & Expo Floor: 8:00 AM – 5:00 PM
📍 Venue: Thomas M. Menino Convention & Exhibition Center (BCEC), 415 Summer St, Boston, MA 02210, United States
🎯 Target Audience: Chief Medical Officers (CMO), Heads of Pharmacovigilance & Patient Safety, Pharmacoepidemiologists, Regulatory Affairs Directors, R&D Data Scientists, and Clinical Safety Software Providers.
✨ Key Exhibition Sectors & Specialized Conference Tracks:
🤖 Generative AI, Automation & PV Technology: Generative AI tools for adverse event processing, automated signal management, predictive risk modeling, and natural language processing (NLP) in clinical monitoring.
📊 Real-World Evidence (RWE) & Pharmacoepidemiology: Post-authorization safety studies (PASS), longitudinal patient registries, real-world data analytics, and benefit-risk evaluation frameworks.
⚖️ Global Regulatory Compliance & Risk Minimization: FDA, EMA, and international agency compliance, REMS program execution, drug safety auditing, and inspection readiness solutions.
💊 Patient-Centric Therapeutics & Consumer Product Safety: Safety vigilance frameworks spanning prescription biopharmaceuticals, medical devices, gene therapies, and OTC products.
🤝 High-Level Keynote Panels, Interactive Roundtables & Strategic Business Matching: Access insights from 250+ world-class safety leaders, engage in interactive pre-congress deep-dive workshops, evaluate live software demonstrations from 100+ solution providers, and network with global biopharma peers during executive leadership receptions!
Transform your drug safety operations live, harness cutting-edge PV automation, and shape international patient safety standards in Boston!
#WorldPatientSafetyCongress #PatientSafetyAmericas #PatientSafety2026 #Pharmacovigilance #DrugSafety #Terrapinn #BostonEvents #BCECBoston #BiotechBoston #PharmaInnovation #HealthTech #AIinPharma #RiskManagement #B2BIndustrialExpo
